High materiality7/10
4D Molecular price target lowered to $32 from $33 at Goldman Sachs
Why it may matterVerify against the original reporting
upside
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs lowers FDMT target to $32 from $33; current price is $11.65, leaving substantial upside potential.
- Target lowered but remains well above current price.
Key facts
- 01
Target: $32
- 02
Posted price: $11.65
- 03
Analyst firm: Goldman Sachs
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.